EP 3 431 475 B1 results from Divisional application EP 2 958 916, filed as
WO 2014/128588. It relates to solid forms of a selective CDK4/6 inhibitor. The compound is known under palbociclib.
Brief outline of the case
The OD found that claim 1 as granted did neither infringe Art 123(2) nor Art 76(1),